Xiaofan Zhang

BOCI Securities Ltd. is the brokerage subsidiary of Hong Kong-based BOCI Asia Ltd., which is owned by Government of China’s China Investment Corp., a sovereign wealth company headquartered in Beijing. Founded in 1983, BOCI Securities offers investors with comprehensive products and services such as sales and trading of equities and structured products, investment advisory and private wealth management.

Everest Clinical Research Services, Inc. operates as a contract research organization, providing clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. Its services include biostatistics and statistical programming, interactive response technologies, regulatory submissions, medical and scientific writing, and clinical operations. The company was founded in 2004 and is headquartered in Markham, Canada.

Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research.

BOCI Research Ltd. is an investment research firm headquartered in Hong Kong. The firm was founded in 1998 and is a subsidiary of BOCI Asia Ltd., ultimately held by Chinese government’s China Investment Corp. BOCI Research primarily provides research reports and analysis on China with a focus on telecommunications, property, media, retail, technology, energy, oil and gas, metals and mining, utilities, financials, and transport and logistics sectors.

Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands.